Cellosaurus cell line IGR-HEU (CVCL

Cross-references
Cell line name	IGR-HEU
Synonyms	IGR-Heu; Institut Gustave Roussy-HEU
Accession	CVCL_A2BA
Resource Identification Initiative	To cite this cell line use: IGR-HEU (RRID:CVCL_A2BA)
Comments	Derived from site: In situ; Lung; UBERON=UBERON_0002048.
Sequence variations	Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Unspecified (PubMed=15634909).
Disease	Lung large cell carcinoma (NCIt: C4450)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Male
Age at sampling	62Y
Category	Cancer cell line
Publications	PubMed=9639386; DOI=10.1002/(SICI)1097-0215(19980703)77:1<7::AID-IJC2>3.0.CO;2-y Asselin-Paturel C., Echchakir H., Carayol G., Gay F., Opolon P., Grunenwald D., Chouaib S., Mami-Chouaib F. Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int. J. Cancer 77:7-12(1998) PubMed=15634909; DOI=10.4049/jimmunol.174.2.871 Thiery J., Abouzahr S., Dorothee G., Jalil A., Richon C., Vergnon I., Mami-Chouaib F., Chouaib S. p53 potentiation of tumor cell susceptibility to CTL involves Fas and mitochondrial pathways. J. Immunol. 174:871-878(2005)
Cell line databases/resources	cancercelllines; CVCL_A2BA
Encyclopedic resources	Wikidata; Q105509642
Polymorphism and mutation databases	IARC_TP53; 21659
Entry history
Entry creation	12-Jan-2021
Last entry update	19-Dec-2024
Version number	6